US Investment Relationship Head

Job Description

Purpose of the Job

\n

Act as the overseas IR representative based in the U.S., this role will drive Innovent’s investor engagement and visibility in US capital markets. Build and deepen relationships with U.S./global investors and analysts, shape and deliver the company’s equity story and valuation framework, provide capital-market feedback, and support potential strategic financing activities to help achieve Innovent’s ambition of growing to be global biopharmaceutical company in 2030.

\n

Main Duties

\n

Capital Market Narrative

\n

\n
• Co-develop with HQ IR team the company’s global investment narrative and valuation framework for international investors, ensuring clear, consistent and compelling messaging to the U.S. and global investor community.
\n

\n

Shareholder Structure Optimization

\n

\n
• Lead systematic and regular investor coverage in the U.S. market; deepen relationships with high-quality overseas investors and support optimization of the shareholder base, with a focus on long-term and specialist shareholders.
\n

\n

US Analyst Coverage

\n

\n
• Expand and maintain positive, continuous coverage from overseas sell-side analysts; drive analyst education, information flow and follow-up to enhance Innovent’s influence in the global investment community.
\n

\n

Overseas IR Event Organization

\n

\n
• Plan and organize overseas IR activities, including roadshows and investor/analyst events around key scientific and financial milestones (e.g., ASCO, ESMO, ADA and major financial conferences), ensuring alignment with HQ IR strategy.
\n

\n

Overseas PR / R&D Collaboration for Brand Building

\n

\n
• Work closely with PR to support Innovent’s overseas corporate brand building; partner with R&D/Medical teams to enhance Innovent’s presence and reputation at global academic and scientific meetings from an investor perspective.
\n

\n

Collaboration with BD and M&A Teams

\n

\n
• Facilitate interaction and connectivity between the overseas investment community and Innovent’s BD and M&A teams, helping convert capital market interest into partnership and transaction opportunities.
\n

\n

Day-to-day Investor Communication & Disclosure Support

\n

\n
• Co-develop with HQ IR investor communication materials, including investor presentations, financial data packs and Q ensure consistency, accuracy and compliance of all overseas investor communications.
\n

\n

\n

Job Qualifications

\n

Education and Qualification

\n

\n
• Bachelor’s degree required.
\n
• Advanced degree preferred: PhD or Master’s in life sciences, pharmacy, medicine, or related field; or MBA/finance-related degree with strong healthcare exposure.
\n

\n

Professional Knowledge

\n

\n
• In-depth understanding of U.S. and international biopharma capital markets and investor/analyst ecosystem.
\n
• Strong familiarity with drug development, clinical trial design/readouts, regulatory milestones and commercial drivers.
\n
• Solid grasp of biotech/pharma valuation approaches (DCF, rNPV, comps, transaction multiples) and key investor metrics.
\n

\n

Work Experience

\n

\n
• 5+ years of relevant experience in:
\n

\n

Investor Relations in biotech/pharma; or

\n

Sell-side equity research or banking (biotech/pharma); or

\n

Buy-side healthcare/biotech investing.

\n

\n
• Direct experience engaging U.S.-based institutional investors and healthcare analysts
\n

\n

Skill Requirement

\n

\n
• Excellent English verbal and written communication; able to independently communicate with global investors.
\n
• Strong capability in preparing investor materials (investor deck/PPT, data packs, press/investor communications).
\n
• Solid financial modeling and basic valuation skills.
\n
• Cross-functional coordination, project management and event organization skills.
\n

\n

Other Requirements

\n

\n
• Strong self-motivation to drive clear results and work independently.
\n